JP4808991B2 - Deodorant film preparation - Google Patents
Deodorant film preparation Download PDFInfo
- Publication number
- JP4808991B2 JP4808991B2 JP2005136740A JP2005136740A JP4808991B2 JP 4808991 B2 JP4808991 B2 JP 4808991B2 JP 2005136740 A JP2005136740 A JP 2005136740A JP 2005136740 A JP2005136740 A JP 2005136740A JP 4808991 B2 JP4808991 B2 JP 4808991B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- oil
- film
- deodorizing
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims description 48
- 239000002781 deodorant agent Substances 0.000 title claims description 15
- 235000019645 odor Nutrition 0.000 claims description 33
- 230000001877 deodorizing effect Effects 0.000 claims description 31
- 239000000284 extract Substances 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000003921 oil Substances 0.000 claims description 22
- 235000019198 oils Nutrition 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 16
- 239000000020 Nitrocellulose Substances 0.000 claims description 14
- 229920001220 nitrocellulos Polymers 0.000 claims description 14
- 235000019441 ethanol Nutrition 0.000 claims description 12
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- 235000004347 Perilla Nutrition 0.000 claims description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims description 10
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 claims description 10
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 claims description 10
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 claims description 10
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 claims description 10
- 230000009471 action Effects 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 claims description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 8
- 235000011803 sesame oil Nutrition 0.000 claims description 8
- 239000008159 sesame oil Substances 0.000 claims description 8
- 150000003464 sulfur compounds Chemical class 0.000 claims description 7
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 6
- 229940041616 menthol Drugs 0.000 claims description 6
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims description 4
- 239000005995 Aluminium silicate Substances 0.000 claims description 4
- 241000241413 Propolis Species 0.000 claims description 4
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 claims description 4
- 235000012211 aluminium silicate Nutrition 0.000 claims description 4
- 239000004359 castor oil Substances 0.000 claims description 4
- 235000019438 castor oil Nutrition 0.000 claims description 4
- 235000020230 cinnamon extract Nutrition 0.000 claims description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 4
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims description 4
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 4
- 239000000419 plant extract Substances 0.000 claims description 4
- 229940069949 propolis Drugs 0.000 claims description 4
- 229960004889 salicylic acid Drugs 0.000 claims description 4
- 239000011787 zinc oxide Substances 0.000 claims description 4
- 229930007845 β-thujaplicin Natural products 0.000 claims description 4
- 240000004385 Centaurea cyanus Species 0.000 claims description 3
- 235000005940 Centaurea cyanus Nutrition 0.000 claims description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 3
- 240000006365 Vitis vinifera Species 0.000 claims description 3
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 3
- 235000014692 zinc oxide Nutrition 0.000 claims description 3
- 241000546188 Hypericum Species 0.000 claims description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 2
- 238000003892 spreading Methods 0.000 claims description 2
- 230000007480 spreading Effects 0.000 claims description 2
- 244000124853 Perilla frutescens Species 0.000 claims 2
- 235000020721 horse chestnut extract Nutrition 0.000 claims 1
- 229910052939 potassium sulfate Inorganic materials 0.000 claims 1
- 235000011151 potassium sulphates Nutrition 0.000 claims 1
- 239000010408 film Substances 0.000 description 43
- 210000003491 skin Anatomy 0.000 description 22
- 230000006872 improvement Effects 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 238000009472 formulation Methods 0.000 description 12
- 210000004243 sweat Anatomy 0.000 description 12
- 241000229722 Perilla <angiosperm> Species 0.000 description 8
- 238000004332 deodorization Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 208000002557 hidradenitis Diseases 0.000 description 7
- 239000006071 cream Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000001166 anti-perspirative effect Effects 0.000 description 5
- 239000003213 antiperspirant Substances 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 238000003287 bathing Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000035943 smell Effects 0.000 description 4
- 210000000106 sweat gland Anatomy 0.000 description 4
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 3
- WERLCVLDMOINSQ-UHFFFAOYSA-N 3-methylbutyl acetate 5-methylhexanoic acid Chemical compound CC(C)CCCC(O)=O.CC(C)CCOC(C)=O WERLCVLDMOINSQ-UHFFFAOYSA-N 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 229940117916 cinnamic aldehyde Drugs 0.000 description 3
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229940117955 isoamyl acetate Drugs 0.000 description 3
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 241000208690 Hamamelis Species 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- -1 isopropylmethyl Chemical group 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 240000006108 Allium ampeloprasum Species 0.000 description 1
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000034655 secondary growth Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000013460 sweaty Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Description
この発明は、身体からの悪臭を防ぐ防臭フィルム製剤に関するものである。 The present invention relates to a deodorizing film preparation for preventing malodor from the body.
従来、身体からの悪臭、特に腋臭(腋臭症)と足の臭いに対しては、こまめに入浴したり、シャワーを浴びたりして汗や汚れを取ったり、脇の毛を剃ったりして細菌の繁殖を抑制する日常のスキンケアーに加えて、制汗・デオドラント剤を使うのが一般的である(例えば、特許文献1)。
しかしながら、その防臭効果は不十分であり、腋臭に関してはアポクリン汗腺の働きを弱める目的で毛穴に針を差し込んで熱を加えることで、アポクリン汗腺の出口を塞ぎ、臭いのもとになる汗が出ないようにする永久脱毛やアポクリン汗腺をはさみで取り除く手術(剪除法)があるが、完璧な方法ではなく、しかも通院に加えて痛みを伴い、肉体的にも金銭的にも負担が大きいのが現状である。
足の臭いに至っては、特別な治療法は無く、足の小まめな洗浄と靴下を履き替えることに加えて、制汗・デオドラント剤を使用するものの、十分な防臭効果を得られていないのが現状である。
又、手袋を利用するスポーツ、レジャー(ゴルフ、野球、レーシング、ドライビング等)に至っては、手袋等の布地自体に防臭剤を塗布すことはあるが、身体自体には全く防臭対策さえ取られていないのが現状である。
However, its deodorizing effect is inadequate, and with respect to scents, by inserting heat into the pores and applying heat to weaken the function of the apocrine sweat gland, the apocrine sweat gland outlet is blocked and sweat that causes odor comes out. There are permanent hair removal and surgery to remove apocrine sweat glands with scissors (pruning method), but it is not a perfect method, and it is painful in addition to going to hospital, and it has a heavy physical and financial burden Currently.
There is no special treatment for the smell of the foot, and in addition to the use of antiperspirant / deodorant agent in addition to the small washing of the foot and changing the socks, it does not have a sufficient deodorizing effect Is the current situation.
Also, in sports and leisure (golf, baseball, racing, driving, etc.) that use gloves, deodorants may be applied to the fabric itself such as gloves, but even the body itself has even taken anti-odor measures. There is no current situation.
ところで、腋臭とは脇の下が臭う状態のことで「腋臭症」というが、臭いの原因は脇の下にかく汗である。この汗を出す汗腺にはエクリン汗腺とアポクリン汗腺の2種類がある。エクリン汗腺は全身にあり、汗を分泌することで体温を調節する役割を担っており、アポクリン汗腺は脇の下や外陰部、乳暈、臍、肛門周囲等の特定部位のみであり、精神的な緊張が強いときに汗を分泌する。
アポクリン汗腺は第2次成長の際に発達するために、性ホルモンと深い関係があると考えられていおり、アポクリン汗腺から出る汗には、タンパク質、脂質、糖などが含まれている。これらの成分の内、特に脂質が皮膚表面の常在菌(住み着いている菌)によって分解され、低級脂肪酸となり独特な臭いの元(腋臭)となる。
また、足の臭いは、足の裏にあるエクリン線から分泌された汗と皮膚の角質層由来のタンパク質が皮膚表面の常在菌によって分解され独特の臭いを発生させる。
By the way, the odor is a state where the armpit smells and is called “smelly odor”, but the cause of the odor is sweat under the armpit. There are two types of sweat glands that produce sweat: eccrine sweat glands and apocrine sweat glands. The eccrine sweat gland is in the whole body and plays a role in regulating body temperature by secreting sweat, and the apocrine sweat gland is only in specific parts such as the armpits, vulva, breasts, navel, and anal area, and there is mental tension. Secretes sweat when strong.
Apocrine sweat glands develop during secondary growth and are therefore considered to be closely related to sex hormones. The sweat produced from apocrine sweat glands contains proteins, lipids, sugars, and the like. Among these components, particularly lipids are decomposed by resident bacteria (resident bacteria) on the skin surface, become lower fatty acids, and have a unique odor (poisonous odor).
In addition, the smell of the foot generates a unique odor by degrading the protein derived from the sweat and the stratum corneum of the skin secreted from the eccrine line on the sole of the foot, by resident bacteria on the skin surface.
腋臭や足の臭いに対する対策としてこまめに入浴したり、シャワーを浴びたり、腋毛を剃って細菌が繁殖しやすい湿気の高い環境を改善する等の日常のスキンケアーに加えて、制汗・デオドラント剤の使用が一般的であるが、しかしながら、市販の制汗・デオドラント剤は局所の収斂作用により汗の穴を一次的に塞いだり、細菌の増殖を防ぐ抗菌成分が含有されているが、いずれも一時的なものであり、防臭効果も不十分で持続性のないものが殆どであった。
製剤もクリーム、軟膏等の外用製剤がほとんどであるが、患部への塗布が手間であり、使用後の手洗いが必要であったり、塗布した製剤で衣服やソックスを汚したりする製剤的欠点が多く、更に日々の入浴やシャワーにより洗い流される確率が高く、その都度塗布し直す必要があった。
Anti-perspirant and deodorant agents in addition to daily skin care, such as taking frequent baths, taking showers, and shaving the eyelashes to improve the high humidity environment where bacteria are likely to propagate However, commercially available antiperspirant / deodorant agents contain antibacterial ingredients that temporarily block sweat holes by local astringent action and prevent bacterial growth. Most of them were temporary, had an insufficient deodorizing effect and were not durable.
Most of the preparations are external preparations such as creams and ointments. However, application to the affected area is troublesome, and there are many formulation defects that require washing after use or soiling clothes and socks with the applied preparation. In addition, there is a high probability of being washed away by daily bathing or showering, and it was necessary to reapply each time.
本発明は、上記の問題点に鑑みてなされたもので、本発明者は、皮膚の上に耐水性の膜を形成させることによって従来の制汗・デオドラント剤の欠点(塗布する手の汚れ、衣服への製剤の付着による汚れ、塗布回数の多いことによる煩雑性、効果とその持続性等)を飛躍的に改善できるものと考え、本発明の課題は、腋臭及び足の臭いを簡便に防止でき、防臭作用の持続性を向上させ、且つ、防臭を効率的に防ぐことが出来る製剤を提供することにある。 The present invention has been made in view of the above problems, and the inventor of the present invention has a drawback of conventional antiperspirant / deodorant agents by forming a water-resistant film on the skin (dirt of hand to be applied, The problem of the present invention is simply to prevent the odor and foot odor. An object of the present invention is to provide a preparation that can improve the sustainability of the deodorizing action and can effectively prevent the deodorization.
本発明者は、腋臭及び足の臭いを簡便に、衛生的に且つ持続的に防止するにはどのような製剤にいかなる物質を使用すればよいかという点についていろいろと考察し、実験を重ねた。
そして、従来のクリーム、軟膏、ジェルといった外用製剤の弱点を考慮した結果、製剤そのものが塗布後に乾燥し、被膜を形成すれば塗布後の製剤による衣服等の汚れや塗布した手の汚れを解消し、患部のODT効果(密封)により薬物の皮膚への浸透性が改善し、薬物の効果と持続性を改善することができた。
更に患部を被膜で被覆することにより、臭いそのものを閉じ込める効果と空気を遮断することにより細菌の増殖を抑制することに加えて、入浴、シャワーによる患部の洗浄による薬剤の喪失も無く、結果として確実で持続的な防臭効果を期待できることに気がついた。発明者は、この事実を基にして更に研究を重ねた結果、この発明を完成させることができた。
The present inventor has conducted various experiments on what kind of substance should be used for what kind of formulation to easily and hygienically and continuously prevent the odor and foot odor. .
As a result of taking into account the weaknesses of conventional external preparations such as creams, ointments, and gels, the preparation itself dries after application, and if a film is formed, it eliminates stains on clothes and applied hands due to the preparation after application. The ODT effect (sealing) of the affected area improved the penetration of the drug into the skin and improved the drug's effect and persistence.
In addition to covering the affected area with a coating, the effect of confining the odor itself and blocking the air by blocking the air, there is also no loss of the drug due to washing the affected area by bathing or showering. I realized that I could expect a lasting deodorant effect. As a result of further research based on this fact, the inventor was able to complete the present invention.
すなわち、上記に課題を解決するために、請求項1の発明は、ニトロセルロースを、酢酸3−メチルブチル(酢酸イソペンチル)、酢酸イソブチル、又はアセトン、或いはこれらの混合物の溶解剤に溶解し、更に、エチルアルコールを添加して製剤としたものであり、皮膚に塗布した後溶剤が揮散し、ニトロセルロースの厚さ10μ〜100μの透明、或いは半透明の被膜を皮膚上に形成することにより患部を密封し、腋臭、足等の臭気の発散を防止することを特徴とする防臭フィルム製剤である。
請求項2の発明は、前記溶解剤の中に天然油を添加して、製剤の流動性と被膜形成後の膜の強靭性を向上させることを特徴とする請求項1に記載の防臭フィルム製剤である。
請求項3の発明は、前記天然油は、シソオイル、ごま油、えごま油、オリーブ油、馬油、ひまし油、ヒノキオイルから選択されることを特徴とする請求項2に記載の防臭フィルム製剤である。
請求項4の発明は、前記製剤の中にサリチル酸、メントール、ハッカ油、シソの実エキス、プロポリス、シナモンエキス(シンナムアルデヒド)、ヒノキチオール、イソプロピルメチルフェノールから選択される抗菌、及び/又は、殺菌作用を有する天然或いは合成物質を添加することを特徴とする請求項1に記載の防臭フィルム製剤である。
請求項5の発明は、製剤の中に、イオウ化合物を含有することを特徴とする請求項1の防臭フィルム製剤である。
請求項6の発明は、前記イオウ化合物は、メチルスルファニルメタン(MSM)であることを特徴とする請求項5の防臭フィルム製剤である。
請求項7の発明は、製剤の中に局所収斂作用を有する物質を含有することを特徴とする請求項1に記載の防臭フィルム製剤である。
請求項8の発明は、前記局所収斂作用を有する物質は、硫酸アルミニウムカリウム、酸化亜鉛、カオリン、植物抽出液(オトギリソウエキス、セイヨウキズタエキス、マロニエエキス、ブドウ葉エキス、シナノエキス、ハマメリスエキス、ヤグルマギクエキス等)から選択される物質であることを特徴とする請求項7に記載の防臭フィルム製剤である。
That is, in order to solve the above-mentioned problem, the invention of
The invention according to
The invention according to
The invention according to
The invention according to
The invention according to
The invention of
According to an eighth aspect of the present invention, the substance having a local astringent action is potassium potassium sulfate, zinc oxide, kaolin, plant extract (hypericum extract, Atlantic kizuta extract, maroni extract, grape leaf extract, shinano extract, hamamelis extract, cornflower) The odor-preventing film preparation according to
したがって、この発明に係る防臭フィルム製剤は、被膜形成体であるニトロセルロースを酢酸イソアミル、酢酸イソブチル、アセトン、或いは、これらの混合物で溶解し、更にエチルアルコールを加えて増量し、この溶解液の中に抗菌剤、収斂剤、天然オイル、イオウ化合物を溶解、含有させたものであり、患部に塗布した溶解剤である酢酸イソアミル、酢酸イソブチル、及び、エチルアルコールが体温により数分で揮発したのち、患部の皮膚表面にニトロセルロースの厚さ10μ〜100μ透明被膜を形成し、この形成した透明皮膜で患部の皮膚を被覆するものである。 Therefore, the deodorizing film preparation according to the present invention dissolves nitrocellulose, which is a film forming body, with isoamyl acetate, isobutyl acetate, acetone, or a mixture thereof, and further increases the amount by adding ethyl alcohol. Antibacterial agents, astringents, natural oils, sulfur compounds are dissolved and contained, and after dissolution of isoamyl acetate, isobutyl acetate, and ethyl alcohol, which are solubilizing agents applied to the affected area, in a few minutes due to body temperature, A nitrocellulose 10 μm to 100 μm transparent film is formed on the skin surface of the affected area, and the affected skin is covered with the formed transparent film.
また、被膜形成体であるニトロセルロースと溶解剤である酢酸イソアミル、酢酸イソブチル、アセトンとの配合比は3:1〜1:10、好ましくは2:1〜1:5、より好ましくは1:1〜1:3であり、ニトロセルロースが多いと皮膚へ均一に塗布し難く、少ないと、密封状のフィルム形成が困難になるからであり、更に、ニトロセルロース溶解液に対するエチルアルコールの添加量は2:1〜1:10、好ましくは1:1〜1:7、より好ましくは1:2〜1:5であり、これも同様の理由である。ここでエチルアルコールを用いたのは、エチルアルコール自体に殺菌効果があり、対象部位を殺菌してからニトロセルロースで密封フィルムを形成することになるので、防臭効果は向上する。
ニトロセルロース溶解液にエチルアルコールを添加して製した基剤に対して、製剤の流動性と被膜形成後の膜の強靭性を向上させるために、シソオイル、ごま油、えごま油、オリーブ油、馬油、ひまし油、ヒノキオイル等の天然オイルを配合してもよく、これら天然油の配合率は0.01%〜20%、好ましくは0.05〜10%、より好ましくは0.1%〜5%が良いが、これも、余り多いと密封状のフィルム形成が困難になるからである。
また、製剤の密封状のフィルム形成が阻害されない程度に、製剤中に配合される抗菌剤であるサリチル酸、メントール、ハッカ油、シソの実エキス、プロポリス、シナモンエキス(シンナムアルデヒド)、ヒノキチオール、イソプロピルメチルフェノール等を配合してもよく、これも同様の理由で0.01%〜20%、好ましくは0.05〜10%、より好ましくは0.1〜5%の範囲内で自由に配合できる。
Further, the blending ratio of nitrocellulose as the film forming body and isoamyl acetate, isobutyl acetate and acetone as the dissolving agent is 3: 1 to 1:10, preferably 2: 1 to 1: 5, more preferably 1: 1. This is because when the amount of nitrocellulose is large, it is difficult to uniformly apply to the skin, and when the amount is small, it is difficult to form a sealed film. Further, the amount of ethyl alcohol added to the nitrocellulose solution is 2 : 1 to 1:10, preferably 1: 1 to 1: 7, more preferably 1: 2 to 1: 5, for the same reason. Here, the use of ethyl alcohol has a bactericidal effect on the ethyl alcohol itself, and after the target portion is sterilized, a sealing film is formed with nitrocellulose, so that the deodorizing effect is improved.
In order to improve the fluidity of the formulation and the toughness of the film after film formation, for the base made by adding ethyl alcohol to the nitrocellulose solution, perilla oil, sesame oil, sesame oil, olive oil, horse oil, Natural oils such as castor oil and hinoki oil may be blended, and the blending ratio of these natural oils is 0.01% to 20%, preferably 0.05 to 10%, more preferably 0.1% to 5%. Although it is good, this is also because it becomes difficult to form a sealed film if it is too much.
In addition, the antibacterial agents salicylic acid, menthol, mint oil, perilla extract, propolis, cinnamon extract (cinnamaldehyde), hinokitiol, isopropylmethyl, which are antibacterial agents incorporated in the formulation, to the extent that the sealed film formation of the formulation is not inhibited Phenol or the like may be blended, and for the same reason, 0.01% to 20%, preferably 0.05 to 10%, more preferably 0.1 to 5% can be blended freely.
更に、本実施例のフィルム製剤にはイオウ化合物であるメチルスルファニルメタン(MSM)を配合してもよく、これは、MSMが皮膚、鼻粘膜、消化管等の上皮組織を強化し、環境毒素、アレルゲンに対するバリアーを強化する役割を果し、また、コラーゲン合成を促し、健康的な肌を作るのに役立つからである。その上、本実施例のフィルム製剤におけるMSMは、皮膚上に膜を形成したときに結晶として膜構成し、汗をかくとその汗によって結晶が溶解し、結果として膜に超微細孔を形成して、皮膚の被れを予防する効果を有し、このことが長期間の製剤使用を可能なものとしている。
このMSMのフィルム製剤に対する配合比は、0.01%〜20%がよく、好ましくは0.05〜10%、より好ましくは0.1〜5%の範囲内で自由に配合であれば、製剤の密封状のフィルム形成が阻害しない。
同様に、局所収斂作用を有する物質である硫酸アルミニウムカリウム、酸化亜鉛、カオリン、植物抽出エキスは0.01%〜10%、好ましくは0.05%〜5%、より好ましくは0.1〜3%の範囲内で自由に配合できる。
Furthermore, methylsulfanylmethane (MSM), which is a sulfur compound, may be blended in the film preparation of this example. This is because MSM strengthens epithelial tissues such as skin, nasal mucosa, gastrointestinal tract, This is because it plays a role in strengthening the barrier against allergens, promotes collagen synthesis, and helps to create healthy skin. In addition, the MSM in the film preparation of this example forms a film as a crystal when a film is formed on the skin. When sweat is applied, the crystal dissolves by the sweat, resulting in the formation of ultrafine pores in the film. Therefore, it has an effect of preventing skin covering, and this makes it possible to use the preparation for a long time.
The blending ratio of the MSM to the film preparation is preferably 0.01% to 20%, preferably 0.05 to 10%, more preferably 0.1 to 5%. The formation of a hermetic film is not hindered.
Similarly, aluminum sulfate potassium, zinc oxide, kaolin, and plant extract, which are substances having a local astringent action, are 0.01% to 10%, preferably 0.05% to 5%, more preferably 0.1 to 3%. % Can be freely blended.
この発明の防臭フィルム製剤によれば、酢酸メチルブチル(酢酸イソペンチル)、酢酸イソブチル、又はアセトンの単体、或いは混合物に溶解したニトロセルロースが溶媒であるエチルアルコールとともに体温にて揮散、蒸発したのちに塗布部位の皮膚上に10μ〜100μ被膜を形成し、患部(発汗部)を被覆することによって患部から発せられる臭いを閉じ込め防臭効果を発揮する。
この患部の密封効果は、空気との直接の接触を避ける為に臭いの発生原因である皮膚常在菌の繁殖を抑制し間接的な防臭効果を発揮する結果となる。又、エチルアルコール自体に殺菌効果があるために上記と同様に防臭効果につながる。
この製剤的な特徴に加えて製剤内に抗菌剤を加えて更に殺菌効果を高め、局所収斂剤を添加することによって汗腺からの汗の発生を抑制し、臭いの原料の供給とそれを分解して臭いを発生させる細菌を抑制する総合的な効果で防臭作用を発揮する。
また、極めて薄い透明フィルムによって患部を被覆するといった製剤的な特徴によって、手を汚したり、衣服やソックスを汚染したり、患部の違和感(ジュクジュク感、皮膚の白濁性)を総て解消することが可能となる。また、皮膚に密着した無色透明の極めて薄いフィルム層であるので、肌が露出するような部位に使用した場合でも、他人が見ても目立つことがない。もっとも、半透明でも、肌が透けて見えれば良いく作用・効果は同様である。
更に、日々の入浴やシャワーにより患部の薬剤が流れ落ちることが無くなるために、確実で且つ持続的な防臭効果がある。
According to deodorizing film preparation of the present invention, methylbutyl acetate (isopentyl acetate), isobutyl acetate, or a single acetone, or volatilization nitrocellulose dissolved in a mixture is at body temperature with ethyl alcohol as a solvent, coating site After evaporation A 10 μm to 100 μm film is formed on the skin and the affected part (sweaty part) is covered to confine the odor emitted from the affected part, thereby exhibiting the deodorizing effect.
This effect of sealing the affected area results in an indirect deodorizing effect by suppressing the growth of the resident skin bacterium, which is the cause of odor generation, in order to avoid direct contact with air. Moreover, since ethyl alcohol itself has a bactericidal effect, it leads to a deodorizing effect as described above.
In addition to the characteristics of this formulation, antibacterial agents are added to the formulation to further enhance the bactericidal effect, and by adding a local astringent, sweat generation from sweat glands is suppressed, and the supply of odor raw materials and decomposition of them are performed. Deodorizing effect with a comprehensive effect of suppressing bacteria that generate odors.
In addition, the formulation features such as covering the affected area with an extremely thin transparent film can contaminate the hands, contaminate clothes and socks, and eliminate all the uncomfortable feelings (jukju sensation, cloudiness of the skin) of the affected area. It becomes possible. In addition, since it is a colorless and transparent very thin film layer that is in close contact with the skin, even if it is used on a part where the skin is exposed, it does not stand out even when viewed by others. However, even if it is translucent, the action and effect are the same as long as the skin can be seen through.
Furthermore, since the medicine in the affected area does not flow down due to daily bathing or showering, there is a reliable and continuous deodorizing effect.
[実施例]
本発明の防臭フィルム製剤の好適な実施例を説明するが、先ず、この実施例の配合比は次の[表1]に示すようなものである。
[Example]
A preferred embodiment of the deodorizing film preparation of the present invention will be described. First, the blending ratio of this embodiment is as shown in the following [Table 1].
[表1][組成比]
ニトロセルロース・・・・・・・・2.0%
エチルアルコール・・・・・・・55.0%
酢酸イソブチル・・・・・・・・20.0%
酢酸3−メチルブチル・・・・・10.0%
メチルスルファニルメタン・・・・3.0%
メントール・・・・・・・・・・・2.0%
シソの実エキス・・・・・・・・・5.0%
硫酸アルミニウムカリウム・・・・3.0%
[Table 1] [Composition ratio]
Nitrocellulose ... 2.0%
Ethyl alcohol ... 55.0%
Isobutyl acetate: 20.0%
3-methylbutyl acetate: 10.0%
Methylsulfanylmethane ... 3.0%
Menthol ... 2.0%
Perilla extract ... 5.0%
Potassium aluminum sulfate ... 3.0%
[調整方法]
上記の組成比になるように、本実施例の防臭フィルム製剤は、次のような手順で調整する。
先ず、ニトロセルロースを酢酸イソブチルに溶解させたのち、更に酢酸イソペンチルを添加して良く攪拌する。次に、この溶解液にエチルアルコールを加えて良く攪拌したのち、メチルスルファニルメタン、メントール、シソの実エキス、更に、ミョウバンと順次攪拌下に少量ずつ添加し、24時間室温放置して製造する。
[Adjustment method]
The deodorant film preparation of this example is prepared by the following procedure so that the composition ratio is as described above.
First, after nitrocellulose is dissolved in isobutyl acetate, isopentyl acetate is further added and stirred well. Next, after adding ethyl alcohol to this solution and stirring well, methylsulfanylmethane, menthol, perilla extract, and alum are added in small portions under sequential stirring and allowed to stand at room temperature for 24 hours for production.
[防臭試験]
上記の組成、及び、調整方法で製造した実施例の防臭フィルム製剤の作用・効果を以下の条件で検証した。
(1)被検体:防臭フィルム製剤
(上記の実施例の製剤:以下「実施例品」という。)
対照製品:通常市販の防臭クリーム
(C社製イソプロピルメチルフェノール配合:以下「比較例品」という。)
(2)被験者:成人ボランティア5名(男性25歳〜38歳)
(3)試験方法:投与量・投与方法及び投与期間
(A)試験初日の入浴後に1回適量を右腋に実施例品を、左腋に比較例品をそれぞれ塗布し、5分後に各々の上から脱脂綿(5cm×5cm、二重)で被覆したのち絆創膏で固定した。その後24時間ごとに脱脂綿を順次取り替えた。そして、取り替えた脱脂綿はそれぞれにビニール袋に入れ密封し、官能試験用サンプルとした。なお、各製剤は原則として初回の塗布1回に限定した。
(B)試験期間は7日間とし、試験期間中は香水、オーデコロン等の香りのするものは一切用いず、更にニンニク、ニラ等の体臭に影響を与える食品の摂取は控えるように各被験者に指示徹底した。
[Odor control test]
The effect | action and effect of the deodorizing film formulation of the Example manufactured with said composition and the adjustment method were verified on the following conditions.
(1) Subject: Deodorant film preparation (Formulation in the above example: hereinafter referred to as “Example product”)
Control product: Ordinary commercially available deodorant cream (Combination of isopropylmethylphenol manufactured by Company C: hereinafter referred to as “comparative product”)
(2) Subjects: 5 adult volunteers (male 25-38 years old)
(3) Test method: Dosage, administration method and administration period
(A) After bathing on the first day of the test, the appropriate amount of the example product was applied to the starboard once, and the comparative product was applied to the left port, and after 5 minutes, each was covered with absorbent cotton (5 cm × 5 cm, double). Later, it was fixed with adhesive bandage. Thereafter, the absorbent cotton was sequentially replaced every 24 hours. The replaced cotton wool was sealed in a plastic bag, and used as a sensory test sample. Each formulation was limited to one application for the first time in principle.
(B) The test period is 7 days. During the test period, do not use any scents such as perfume and eau de cologne, and instruct each subject to refrain from taking foods that affect body odor such as garlic and leek. Thorough.
(4)観察項目:ビニール袋から被験者の両腋に装着した脱脂綿をそれぞれ取り出し、三名の臭い鑑定人によってその臭いの強度を下記の基準に従って判定した。
判定は三名の鑑定人の内、中間の判定結果を採用した。
(5)臭い程度判定基準
3: かなりきつい
2: きつい
1: 僅かに臭う
0: 殆ど臭わない
上記の評価基準したがっての実験結果が、図1の[表2]の「防臭効果試験成績」の数値である。
(6)臭いの改善判定基準
[表2]の「防臭効果試験成績」の結果から、臭いの改善度を、原則として下記の基準に従って4段階に区分して判定した。
著明改善(++): 3→0 2→0
改善 (+ ) : 3→2 3→1 2→1 1→0
不変 (±) : 3→3 2→2 1→1
悪化 (−) : 悪化したもの
上記基準にしたがって、著明改善(++)、改善(+)、不変(±)、悪化(−)で表したのが、図2の[防臭改善度1]の[表3]であり、これを人数として表したのが、図3の[防臭改善度1]の[表4]であり、更に、作用効果の比較を明確にするために、改善割合を%で表したのが、図4の「判定日毎の改善率」の[表5]である。
(4) Observation items: Absorbent cotton worn on both sides of the subject was taken out from the plastic bag, and the odor intensity was determined by three odor appraisers according to the following criteria.
Judgment was performed using an intermediate judgment result among the three appraisers.
(5) Odor degree criteria 3: Quite 2: Slight 1: Smell 0: Slightly odor 0: Almost no odor The above evaluation criteria and the experimental results are shown in Table 2 in FIG. It is.
(6) Odor improvement criteria
From the results of “Deodorization effect test results” in [Table 2], the odor improvement degree was determined in four stages according to the following criteria in principle.
Significant improvement (++): 3 → 0 2 → 0
Improvement (+): 3 → 2 3 → 1 2 → 1 1 → 0
Invariant (±): 3 → 3 2 → 2 1 → 1
Deterioration (-): Deterioration According to the above criteria, marked improvement (++), improvement (+), unchanged (±), and deterioration (-) are shown in [Deodorization improvement degree 1] in FIG. This is [Table 3], and this is expressed as the number of people in [Table 4] of [Deodorization improvement degree 1] in FIG. 3. Further, in order to clarify the comparison of the effect, the improvement ratio is expressed in%. This is expressed in [Table 5] of “improvement rate for each judgment day” in FIG.
(7)使用感
製剤の塗り易さ、塗った後の状態等を総合的に判断し、比較例品に対する本実施例の評価をアンケート形式で取った。
1:非常によい。2:良い。3:変わらない。4:悪い
この結果は、「1:非常によい。」は4人、「2:良い」は1人、「3:変わらない」と「4:悪い」は0人であった。これをグラフにしたのが、図5の比較例品と比較した本実施例品の「使用感」の円グラフである。
(7) Feeling of use The ease of application of the preparation, the state after application, etc. were comprehensively judged, and the evaluation of this example for the comparative product was taken in a questionnaire format.
1: Very good. 2: Good. 3: No change. 4: Bad As a result, “1: very good” was 4, “2: good” was 1, “3: not changed” and “4: bad” were 0. That did this in the graph, a pie chart "feel" of the present embodiment product in comparison with comparative examples of FIG.
[試験結果の検証]
試験結果から、その効果を検証する。
図1の[表2]の「防臭効果試験成績」の成績結果を基にして作成した、最終結果の図4[表5]の「判定日毎の改善率」から判ることは、実施例品の防臭フィルム製剤は、塗布後1日目に被験者の80%が「著明改善」を示し、以後3日まで維持し4日目から5日目は60%、その後6日目40%、7日目20%と経時的に徐々に「著明改善」率は低減したが、「改善」以上では試験期間中100%を維持した。
これに対して比較例の市販クリームは塗布後1日目から「著明改善」は1度だけしか認められず、以後試験終了の7日目まで変化は認められなかった。
また、ランクを下げ、比較例品は「改善」以上のランクにしても、塗布後1日目から3日目までは100%を維持したが4日目60%、5日目40%と低減し、6日目から試験終了の7日目までは0%であり、全く防臭効力は認められなかった。
[Verification of test results]
The effect is verified from the test results.
It can be seen from the “improvement rate for each judgment day” in FIG. 4 [Table 5] of the final result created based on the results of “Deodorization effect test results” in [Table 2] in FIG. On the first day after application, 80% of the subjects showed “significant improvement” in the deodorizing film preparation, and maintained until 3 days thereafter, 60% from the 4th day to the 5th day, then 40% on the 6th day, 7th day. Although the rate of “significant improvement” gradually decreased with time of 20% over time, 100% was maintained during the test period above “improvement”.
On the other hand, in the commercial cream of the comparative example, “significant improvement” was observed only once from the first day after application, and thereafter no change was observed until the seventh day after the end of the test.
In addition, even if the rank was lowered and the comparative product was ranked “improvement” or higher, 100% was maintained from the first day to the third day after application, but it was reduced to 60% on the fourth day and 40% on the fifth day. However, it was 0% from the sixth day to the seventh day after the end of the test, and no deodorizing effect was observed.
以上の結果から、本発明に元づく防臭フィルム製剤の実施例品は、従来の防臭を目的としたクリーム製剤である比較例に比較して遥かに確実でかつ持続性に優れた防臭効果を有する製剤であることが判る。
更に、図5のグラフからも、使用感のアンケート結果、防臭フィルム製剤の実施例品は従来の防臭クリーム製剤の比較例品に比較して、非常に良いが80%、良いが20%、良い以上で100%であり使用感においても本実施例品が市販の比較例品よりも遥かに使用感に優れた製剤であることが明確になった。
From the above results, the example products of the deodorizing film preparation based on the present invention have a deodorizing effect that is far more reliable and superior in sustainability than the comparative example that is a cream preparation aiming at conventional deodorizing. It turns out that it is a formulation.
Furthermore, from the graph of FIG. 5, the results of the questionnaire on the feeling of use indicate that the example product of the deodorant film preparation is very good compared with the comparative example product of the conventional deodorant cream preparation, but 80% is good, but 20% is good Thus, it was clarified that the product of this example was far superior in usability than the commercially available comparative product in terms of usability.
なお、本発明の特徴を損なうものでなければ、上述した実施例に限定されるものでないことは勿論であり、溶解剤として酢酸3−メチルブチル(酢酸イソペンチル)、又は酢酸イソブチル、アセトンは単独でもよく、或いは、酢酸3−メチルブチル(酢酸イソペンチル)、又は酢酸イソブチル、又はアセトンとを混合してもよく、製剤の流動性と被膜形成後の膜の強靭性を向上させるため、シソオイル、ごま油、えごま油、オリーブ油、馬油、ひまし油、ヒノキオイル等の天然油を添加してもよく、抗菌、及び/又は、殺菌作用を有するサリチル酸、メントール、ハッカ油、シソの実エキス、プロポリス、シナモンエキス(シンナムアルデヒド)、ヒノキチオール、イソプロピルメチルフェノール等の天然或いは合成物質を添加してもよく、メチルスルファニルメタン(MSM)等のイオウ化合物を含有させてもよく、局所収斂作用を有する物質の硫酸アルミニウムカリウム、酸化亜鉛、カオリン、植物抽出液(オトギリソウエキス、セイヨウキズタエキス、マロニエエキス、ブドウ葉エキス、シナノエキス、ハマメリスエキス、ヤグルマギクエキス等)等を含有させても良い。 In addition, as long as the characteristics of the present invention are not impaired, the present invention is not limited to the above-described examples, and 3-methylbutyl acetate (isopentyl acetate), isobutyl acetate, or acetone may be used alone as a solubilizer. Alternatively, 3-methylbutyl acetate (isopentyl acetate), or isobutyl acetate, or acetone may be mixed. In order to improve the fluidity of the preparation and the toughness of the film after film formation, perilla oil, sesame oil, sesame oil Natural oils such as olive oil, horse oil, castor oil and cypress oil may be added, and antibacterial and / or bactericidal salicylic acid, menthol, mint oil, perilla seed extract, propolis, cinnamon extract (cinnamaldehyde) ), Natural or synthetic substances such as hinokitiol and isopropylmethylphenol may be added, Sulfur compounds such as tilsulfanyl methane (MSM) may be included, and potassium aluminium sulfate, zinc oxide, kaolin, plant extracts (hyperperum extract, horseshoe extract, maronier extract, grape leaf extract) that have local astringent action , Shinano extract, Hamamelis extract, cornflower extract, etc.) and the like.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005136740A JP4808991B2 (en) | 2005-05-09 | 2005-05-09 | Deodorant film preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005136740A JP4808991B2 (en) | 2005-05-09 | 2005-05-09 | Deodorant film preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006312615A JP2006312615A (en) | 2006-11-16 |
| JP4808991B2 true JP4808991B2 (en) | 2011-11-02 |
Family
ID=37534253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005136740A Expired - Fee Related JP4808991B2 (en) | 2005-05-09 | 2005-05-09 | Deodorant film preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4808991B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4836146B2 (en) * | 2006-10-24 | 2011-12-14 | 有限会社日本健康科学研究センター | Film formulation that forms a film on the skin |
| JP5074091B2 (en) * | 2007-05-07 | 2012-11-14 | 有限会社日本健康科学研究センター | Film repellent to prevent mosquito bites |
| JP5950528B2 (en) * | 2011-09-30 | 2016-07-13 | 小林製薬株式会社 | Film-forming external preparation |
| JP6019441B2 (en) * | 2012-09-28 | 2016-11-02 | 三笠製薬株式会社 | Transdermal absorption odor care tape |
| JP6067342B2 (en) * | 2012-11-16 | 2017-01-25 | 花王株式会社 | Sheet cosmetic |
| JP2014122173A (en) * | 2012-12-20 | 2014-07-03 | Nippon Kenko Kagaku Kenkyu Center:Kk | Insecticidal and repelling preparation forming film |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0636814B2 (en) * | 1985-08-03 | 1994-05-18 | 久光製薬株式会社 | External composition having film-forming ability |
| JPH07103007B2 (en) * | 1993-06-24 | 1995-11-08 | 住友化学工業株式会社 | Cosmetics |
| JP2001513747A (en) * | 1996-01-18 | 2001-09-04 | トランスダーマル セラピューティクス インコーポレイテッド | Antifungal nail lacquer and its preparation |
| US20030049290A1 (en) * | 2001-08-31 | 2003-03-13 | Jha Brajesh Kumar | Deodorant composition |
| US20030118655A1 (en) * | 2001-12-21 | 2003-06-26 | Nikhil Kundel | Film forming liquid composition |
| JP3930416B2 (en) * | 2002-10-30 | 2007-06-13 | 株式会社東洋新薬 | Skin preparation |
| FR2848827B1 (en) * | 2002-12-24 | 2005-06-17 | Oreal | USE OF DIALKYLSULFONES IN COSMETIC NAIL CARE COMPOSITIONS TO PROMOTE NAIL PUSH |
| JP4040531B2 (en) * | 2003-05-30 | 2008-01-30 | 株式会社日立製作所 | Diffusion-supplemented electron source and electronic application device |
| US20050191270A1 (en) * | 2004-02-27 | 2005-09-01 | Hydromer, Inc. | Anti-infectious hydrogel compositions |
| JP4863437B2 (en) * | 2005-07-07 | 2012-01-25 | 有限会社日本健康科学研究センター | Bath film formulation |
-
2005
- 2005-05-09 JP JP2005136740A patent/JP4808991B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006312615A (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20260115115A1 (en) | Tyrothricin for use in the treatment or prophylaxis of body odour and preparations therefor | |
| JP4808991B2 (en) | Deodorant film preparation | |
| JP2000053532A (en) | Beatifying | |
| US5453266A (en) | Powdered body deodorant composition | |
| JP2003081801A (en) | Deodorant cosmetic | |
| JP3886890B2 (en) | Odor prevention cosmetics | |
| HU230398B1 (en) | Medicine for preventing and treating bromhidrosis | |
| JP6118089B2 (en) | Cosmetic composition | |
| US20040076694A1 (en) | Peppermint isopropyl alcohol | |
| ES3021339T3 (en) | Deodorant composition | |
| Lamb | Sodium bicarbonate: an excellent deodorant | |
| JP2001278764A (en) | Transparent solid axillary odor inhibitor and manufacturing method | |
| JP3104401U (en) | Sleep sheet | |
| JP2011236174A (en) | Cosmetic containing powder of vetiver | |
| JPS5936607A (en) | Deodorizing and antiperspirant embrocation | |
| JP2008184395A (en) | Antiperspirant / deodorant cosmetic and method for producing the same | |
| JPS5883612A (en) | Deodorant and sweatproof coating agent | |
| JP2017145250A (en) | Nail composition | |
| JPH10158162A (en) | Liquid composition for antimicrobial agent and therapeutic agent for dermatopathy | |
| JPS60233009A (en) | Deodorant composition | |
| JP2000212053A (en) | Agent for protecting and deodorizing skin | |
| US20050152998A1 (en) | Peppermint isopropyl alcohol | |
| JP2001220314A (en) | Method for producing agent for health and beauty containing sake lees and sake as main raw materials and agent for health and beauty obtained by the method of production | |
| TW201628595A (en) | Composition for external use and use thereof | |
| JP2000212019A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080328 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100812 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100825 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100910 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110815 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110818 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140826 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4808991 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |